From Laurus Labs To Alkem: SEBI Analysts Spot Bullish Setups In These Five Stocks For Short-Term Trades

Stocks like MCX and Windlas Biotech are showing strong technical momentum, according to analysts.
Rising stock market chart on a trading board background.
Rising stock market chart on a trading board background. | Image source: Yuichiro Chino on Getty Images
Profile Image
Preeti Ayyathurai·Stocktwits
Updated Mar 05, 2026   |   2:29 PM EST
Share
·
Add us onAdd us on Google
Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...

Indian equity markets remain in a tight range in the weekly expiry session on Thursday. However, pockets of opportunity are emerging, with SEBI-registered analysts Kavita Agrawal and Vinay Taparia flagging bullish opportunities across stocks such as Laurus Labs, Alkem and MCX, among others. 

Let’s take a look at their stock recommendations: 

Laurus Labs

Read Next
Loading...
Loading...

Advertisement|Remove ads.

Agrawal highlighted the strong underlying momentum in Laurus Labs. On the 75-minute chart, its Relative Strength Index (RSI) is signaling a possible continuation of the uptrend, and increasing volumes show active buying interest. 

She identified support at ₹832 (recently bounced sharply from this level) and resistance at ₹1,090.

Advertisement|Remove ads.

Multi Commodity Exchange (MCX)

MCX shares are in an upward momentum, with their price action breaking past previous highs, showing a bullish structure. 

Agrawal noted that a short-term pullback could give traders a perfect entry point before the next potential rally. She identified the entry zone at ₹8,072 (if price pulls back here), with support at ₹7,910 (to protect downside risk), and resistance at ₹8,870 (based on price structure & volume profile).

Advertisement|Remove ads.

Volumes on the 75-minute chart show solid buying support in the current zone, increasing the probability of an upward bounce and making it favorable for a short-term swing trade.

Windlas Biotech

Advertisement|Remove ads.

On its weekly chart, Windlas has retested key levels after a minor correction, with the 250-day EMA acting as a rock-solid support. Every rally in price is backed by positive volume activity, which is a healthy sign for any long-term trend.

On the daily chart, she noted that the momentum has turned positive again, with strong volumes. 

According to Agrawal, the 250 EMA zone looks like a great accumulation point on a pullback. Resistance is seen at ₹1,473 (near the trendline), which, if broken, can take the stock to ₹2,264 in the longer term. On the other hand, she cautioned that if it breaks below the 250 EMA again, it’s best to exit and reassess the position.

Advertisement|Remove ads.

Himadri Specialty Chemicals (HSCL)

According to Taparia, HSCL has formed a doji candle near the demand zone, followed by a good bullish candle, supported by volumes. The stock can move to ₹535 levels in the short term, but any correction till ₹440 should be used as a buying opportunity.

Advertisement|Remove ads.

Alkem Laboratories 

Alkem has given a good breakout with huge volumes. It can move to ₹5,425-₹5,650 in the short term, with ₹4,800 acting as a good support. A close below ₹4,700 negates this view, Taparia added.

Advertisement|Remove ads.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Comments
Share your thoughts...

Comments posted here will also appear on symbol pages.

Follow on Google News
Read about our editorial guidelines and ethics policy

Advertisement|Remove ads.